SBIO · ALPS Medical Breakthroughs ETF ETF
ALPS ETF TRUST
$67.66
+0.52%
At close · Sep 4
Net assets $161,792,296
Holdings82
1 month
+0.07%
Year to date
+32.10%
52-week range
$35.43–$70.85
30-session avg volume
38,588
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Exchange-traded product
- SEC series
- S000047823
- Report date
- May 31, 2026
- Holdings coverage
- Tracked U.S. equities
Portfolio concentration
Top 10 holdings—
Calculated only when the SEC filing is stored with complete portfolio coverage.
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Alkermes Plc | ALKS | $7,244,993 | 4.48% |
| Kymera Therapeutics Inc | KYMR | $6,851,819 | 4.23% |
| Celcuity Inc | CELC | $6,337,446 | 3.92% |
| Mirum Pharmaceuticals Inc | MIRM | $6,313,199 | 3.90% |
| Spyre Therapeutics Inc | SYRE | $5,950,413 | 3.68% |
| Cg Oncology Inc | CGON | $5,421,223 | 3.35% |
| Apogee Therapeutics Inc | APGE | $4,741,285 | 2.93% |
| Xenon Pharmaceuticals Inc | XENE | $4,692,879 | 2.90% |
| Travere Therapeutics Inc | TVTX | $4,484,506 | 2.77% |
| Dianthus Therapeutics Inc | DNTH | $4,263,485 | 2.64% |
| Newamsterdam Pharma Co Nv | NAMS | $3,991,552 | 2.47% |
| Viking Therapeutics Inc | VKTX | $3,899,596 | 2.41% |
| Crinetics Pharmaceuticals Inc | CRNX | $3,835,561 | 2.37% |
| Acadia Pharmaceuticals Inc | ACAD | $3,806,528 | 2.35% |
| Edgewise Therapeutics Inc | EWTX | $3,777,276 | 2.33% |
| Denali Therapeutics Inc | DNLI | $3,439,346 | 2.13% |
| Oruka Therapeutics Inc | ORKA | $2,920,413 | 1.81% |
| Structure Therapeutics Inc | GPCR | $2,872,607 | 1.78% |
| Disc Medicine Inc | IRON | $2,736,466 | 1.69% |
| Ideaya Biosciences Inc | IDYA | $2,667,624 | 1.65% |
| Vera Therapeutics Inc | VERA | $2,612,567 | 1.61% |
| Tarsus Pharmaceuticals Inc | TARS | $2,605,878 | 1.61% |
| Relay Therapeutics Inc | RLAY | $2,588,347 | 1.60% |
| Mineralys Therapeutics Inc | MLYS | $2,569,707 | 1.59% |
| Celldex Therapeutics Inc | CLDX | $2,156,569 | 1.33% |
| Zai Lab Ltd | ZLAB | $2,034,898 | 1.26% |
| Pharvaris Nv | PHVS | $1,991,344 | 1.23% |
| Sionna Therapeutics Inc | SION | $1,985,949 | 1.23% |
| Rapport Therapeutics Inc | RAPP | $1,945,928 | 1.20% |
| Sarepta Therapeutics Inc | SRPT | $1,933,927 | 1.20% |
| Lakefront Biotherapeutics Nv | LKFT | $1,926,241 | 1.19% |
| Tyra Biosciences Inc | TYRA | $1,854,556 | 1.15% |
| Novavax Inc | NVAX | $1,842,401 | 1.14% |
| Stoke Therapeutics Inc | STOK | $1,819,764 | 1.12% |
| Agios Pharmaceuticals Inc | AGIO | $1,775,525 | 1.10% |
| Vericel Corp | VCEL | $1,743,459 | 1.08% |
| Nuvation Bio Inc | NUVB | $1,707,703 | 1.06% |
| Palvella Therapeutics Inc | PVLA | $1,669,812 | 1.03% |
| Taysha Gene Therapies Inc | TSHA | $1,657,383 | 1.02% |
| Amylyx Pharmaceuticals Inc | AMLX | $1,634,939 | 1.01% |
| Immatics Nv | IMTX | $1,590,567 | 0.98% |
| Immunocore Holdings Plc | IMCR | $1,509,618 | 0.93% |
| Mbx Biosciences Inc | MBX | $1,456,620 | 0.90% |
| Bicara Therapeutics Inc | BCAX | $1,420,558 | 0.88% |
| Moonlake Immunotherapeutics | MLTX | $1,418,054 | 0.88% |
| Kalvista Pharmaceuticals Inc | 483497103 | $1,400,061 | 0.87% |
| Arrivent Biopharma Inc | AVBP | $1,379,192 | 0.85% |
| Oculis Holding Ag | OCS | $1,354,188 | 0.84% |
| Maze Therapeutics Inc | MAZE | $1,312,469 | 0.81% |
| Mannkind Corp | MNKD | $1,197,269 | 0.74% |